Hamstra DA, Mariados N, Sylvester J, et al. Sexual quality of life following prostate intensity modulated radiation therapy (IMRT) with a rectal/prostate spacer: Secondary analysis of a phase 3 trial.Pract Radiat Oncol. 2018;8:e7–e15. ...
PC cells [253]. In addition, the polypeptide based nanocarriers loaded with doxorubicin have been shown to raise the oxidative damage, which eventually inhibited the metastasis of PC in mouse [254]. Several nanocarriers have been made to deliver the platinum-based agents to PC cells [255,256,2...
Its active component is a radionuclide that releases radiation to PSMA-positive cells and their surrounding cells, causing DNA damage and leading to cell death. An international, multicenter, open-label, phase III clinical trial, the VISION study, showed that among 831 patients who had previously ...
SpaceOAR Hydrogel is a rectal spacer designed to minimize the side effects of radiation therapy for prostate cancer. Preserve quality of life with SpaceOAR
R.; Haraf, D. J.; Vijaya- kumar, S.; Chen, G. T. Y. Correlation of late radiation rectal damage and dose surface histograms in prostate pa- tients treated by high dose conformal radiotherapy. (abstr.) Int. J. Radiat. Oncol. Biol. Phys. Suppl. 27:237-238; 1993....
due to the low specificity of therapy. Increasing the radiation dose to achieve adequate anti-cancer effects can cause damage to the healthy tissues and result in adverse impacts. New techniques, such as proton and carbon ion therapy, maximize their effect on tumor cells while minimizing their ef...
The competition between radiation, brachytherapy, and surgery involves a simple goal: men want a treatment that has a high chance of curing the cancer, but a low chance of side effects. Treatment can cause impotence, incontinence, or rectal damage, and that can be a very high price to pay...
(2005) Increased risk of rectal cancer after prostate radiation: a population-based study. Gastroenterology 128: 819–824 Radiation therapy for prostate cancer has been linked to an elevated risk of bladder cancer and other pelvic malignancies. A recent study by Baxter et al. now reveals that ...
In 1936 prostatic acid phosphatase (PAP) became the key serum marker for monitoring prostate cancer (PCa) treatment (1–3). Approximately 50 yr later, prostate-specific antigen (PSA) emerged as the most useful serum marker for PCa management followed a f
Radioactive seeds (brachytherapy) deliver radiation to the prostate with little damage to nearby tissues. Your doctor implants the tiny radioactive seeds, each like a grain of rice, in the prostate gland using ultrasound guidance. The implants remain in place permanently and become inactive after ...